374 related articles for article (PubMed ID: 21841799)
1. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
[TBL] [Abstract][Full Text] [Related]
2. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.
Venable A; Mitalipova M; Lyons I; Jones K; Shin S; Pierce M; Stice S
BMC Dev Biol; 2005 Jul; 5():15. PubMed ID: 16033656
[TBL] [Abstract][Full Text] [Related]
3. Toward safer regenerative medicine.
Andrews PW
Nat Biotechnol; 2011 Sep; 29(9):803-5. PubMed ID: 21904323
[No Abstract] [Full Text] [Related]
4. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
[TBL] [Abstract][Full Text] [Related]
5. Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells.
Rossdam C; Brand S; Beimdiek J; Oberbeck A; Albers MD; Naujok O; Buettner FFR
Glycobiology; 2024 Apr; 34(4):. PubMed ID: 38349796
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cells: Basic biology or else differentiations aimed at translational research and the role of flow cytometry.
Bose B; Nihad M; P SS
Cytometry A; 2023 May; 103(5):368-377. PubMed ID: 36918734
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
[TBL] [Abstract][Full Text] [Related]
8. In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2.
Tan HL; Tan BZ; Goh WXT; Cua S; Choo A
Biotechnol Bioeng; 2019 Nov; 116(11):2996-3005. PubMed ID: 31388993
[TBL] [Abstract][Full Text] [Related]
9. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS).
Fong CY; Peh GS; Gauthaman K; Bongso A
Stem Cell Rev Rep; 2009 Mar; 5(1):72-80. PubMed ID: 19184635
[TBL] [Abstract][Full Text] [Related]
10. Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2.
Polanco JC; Wang B; Zhou Q; Chy H; O'Brien C; Laslett AL
J Vis Exp; 2013 Dec; (82):50856. PubMed ID: 24335647
[TBL] [Abstract][Full Text] [Related]
11. Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis.
Müller T; Eildermann K; Dhir R; Schlatt S; Behr R
Hum Reprod; 2008 Oct; 23(10):2292-8. PubMed ID: 18621756
[TBL] [Abstract][Full Text] [Related]
12. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.
Nagaoka M; Kobayashi M; Kawai C; Mallanna SK; Duncan SA
PLoS One; 2015; 10(8):e0136350. PubMed ID: 26308339
[TBL] [Abstract][Full Text] [Related]
13. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
[TBL] [Abstract][Full Text] [Related]
14. Novel surface-enhanced Raman scattering-based assays for ultra-sensitive detection of human pluripotent stem cells.
Han J; Qian X; Wu Q; Jha R; Duan J; Yang Z; Maher KO; Nie S; Xu C
Biomaterials; 2016 Oct; 105():66-76. PubMed ID: 27509304
[TBL] [Abstract][Full Text] [Related]
15. Cell surface markers in human embryonic stem cells.
Rao RR; Johnson AV; Stice SL
Methods Mol Biol; 2007; 407():51-61. PubMed ID: 18453248
[TBL] [Abstract][Full Text] [Related]
16. Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment.
Stewart MH; Bossé M; Chadwick K; Menendez P; Bendall SC; Bhatia M
Nat Methods; 2006 Oct; 3(10):807-15. PubMed ID: 16990813
[TBL] [Abstract][Full Text] [Related]
17. Adult human pancreas-derived cells expressing stage-specific embryonic antigen 4 differentiate into Sox9-expressing and Ngn3-expressing pancreatic ducts in vivo.
Lee S; Lee CM; Kim SC
Stem Cell Res Ther; 2016 Nov; 7(1):162. PubMed ID: 27836003
[TBL] [Abstract][Full Text] [Related]
18. Derivation of three clones from human embryonic stem cell lines by FACS sorting and their characterization.
Sidhu KS; Tuch BE
Stem Cells Dev; 2006 Feb; 15(1):61-9. PubMed ID: 16522163
[TBL] [Abstract][Full Text] [Related]
19. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
20. Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.
Adler-Wailes DC; Kramer JA; DePamphilis ML
Stem Cells Dev; 2017 Feb; 26(4):285-302. PubMed ID: 27821018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
